Laboratory examination
1. Abdominal ascites cytology examination: percutaneous puncture of the lower abdominal iliac fossa, if there is little ascites, it can be punctured through the posterior fornix, and the ascites is examined for cancer cells.
2. Tumor marker measurement:
(1) CA125: CA125 has important reference value for the diagnosis of ovarian epithelial cancer, especially in serous cystadenocarcinoma, followed by endometrioid cancer. The positive rate of serous cystadenocarcinoma is over 80%, and the level of CA125 is over 90% with the relief or deterioration of the condition. Therefore, it can also be used as a monitoring method after treatment. The positive rate of advanced ovarian cancer is high, but the positive rate of stage I ovarian malignant tumors is only 50%. Clinically, CA125≥35U/ml is the standard for positivity. CA125 is not specific. The CA125 level is sometimes elevated in some gynecological non-malignant diseases such as acute pelvic inflammatory disease, endometriosis, pelvic and abdominal tuberculosis, ovarian cysts, fibroids, and some non-gynecological diseases.
(2) AFP: AFP has specific value for ovarian endodermal sinus tumors, mixed tumors containing endodermal sinus tumor components, dysgerminoma, and embryonal tumors. A certain amount of AFP can also be elevated in some immature teratoma. AFP can be an important marker for the treatment and follow-up of germ cell tumors. Normal values
(3) HCG: Patients with germ cell tumors containing primary ovarian choriocarcinoma components have abnormally elevated HCG levels in the blood, and the HCG value of the B subunit in the serum of normal non-pregnant women is negative or
(4) CEA: In the late stage of some ovarian malignant tumors, especially in mucinous cystadenocarcinoma, CEA is abnormally elevated, but it is not a specific antigen for ovarian tumors.
(5) LDH: LDH levels in the serum of some ovarian malignant tumors are elevated, especially in dysgerminoma.
3. Non-ovarian tumor-specific indicators:
Sex hormones: granulosa cell tumors and theca luteinoma can produce high levels of estrogen; during luteinization, testosterone, serous, mucinous, or fibrous epithelioma can also secrete a certain amount of estrogen.
4. Flow cytometry cell DNA measurement: Flow cytometry (Fcm) method through flow cytometry analysis of tumor DNA content, ovarian malignant tumor DNA content is related to tumor histological classification, grading, clinical staging, recurrence and survival rate.
Imaging examination
1. Ultrasound examination: It is an important means of diagnosing ovarian tumors, which can judge the size, location, texture of the tumor, its relationship with the uterus, and whether there is ascites, etc. The judgment of benign and malignant is based on experience, which can reach 80% to 90%, but the diagnosis of tumors less than 2cm is difficult by ultrasound, and vaginal ultrasound examination, especially vaginal color Doppler ultrasound examination, can show the changes of blood flow inside the tumor, which can provide reference for distinguishing benign from malignant.
2. CT and MRI examination: It is of certain value in judging the size, texture of the tumor, its relationship with the pelvic organs, especially for the enlargement of the pelvic and para-aortic lymph nodes.
3. Lymphangiography: It can show the iliac vessels and para-aortic lymph nodes and their metastatic signs, provide preoperative estimation and preparation for lymph node dissection.
4. Necessary to choose the following examinations
Gastroscopy, colonoscopy: To differentiate primary gastrointestinal primary cancer from ovarian metastatic cancer.
Intravenous pyelography: To understand the secretory and excretory function of the kidneys, symptoms of urinary tract compression and obstruction.
Radionuclide imaging: Use radioactive nuclides labeled antibodies as tumor positive imaging agents for tumor localization diagnosis.
Laparoscopic examination: For pelvic masses that are difficult to定性 in clinical diagnosis, laparoscopic biopsy is performed in patients with ascites, and ascites is taken for pathological and cytological examination for qualitative and preliminary clinical staging.